Competitive antagonism of pressor responses to angiotensin II and angiotensin III by the angiotensin II-1 receptor ligand losartan

Can J Physiol Pharmacol. 1992 May;70(5):716-9. doi: 10.1139/y92-093.

Abstract

Losartan (DuP 753) and PD123177 are nonpeptide angiotensin (ANG) receptor ligands for subtypes of ANG II receptors ANG II-1 and ANG II-2, respectively. We examined the effects of losartan and PD123177 on dose - mean arterial pressure (MAP) response curves for ANG II and ANG III in eight groups (n = 6 each) of conscious rats. Saline (0.9% NaCl), losartan (1 x 10(-6) and 9 x 10(-6) mol/kg), and PD123177 (2 x 10(-5) mol/kg) were i.v. bolus injected 15 min before the construction of ANG II dose - response curves in groups I, II, III, and IV, respectively. Groups V-VIII were treated similarly to I-IV except that ANG III was given in place of ANG II. Losartan dose dependently shifted the dose-response curves of ANG II and ANG III to the right with similar dissociation constants (-log KI of 6.6 +/- 0.7 and 6.6 +/- 0.1 mol/kg, respectively) and no change in the maxima. PD123177 affected neither maximum MAP nor ED50 values for ANG II or ANG III. Our results show that losartan but not PD123177 is a competitive antagonist of the MAP effects of ANG II and ANG III.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / antagonists & inhibitors*
  • Angiotensin III / antagonists & inhibitors*
  • Angiotensin Receptor Antagonists*
  • Animals
  • Biphenyl Compounds / pharmacology*
  • Blood Pressure / drug effects*
  • Dose-Response Relationship, Drug
  • Imidazoles / pharmacology*
  • Losartan
  • Male
  • Pyridines / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Tetrazoles / pharmacology*

Substances

  • Angiotensin Receptor Antagonists
  • Biphenyl Compounds
  • Imidazoles
  • Pyridines
  • Tetrazoles
  • Angiotensin II
  • PD 123177
  • Angiotensin III
  • Losartan